The experts rated focused ultrasound as disruptor #5, following early diagnosis and treatment of Alzheimer’s, stem cell therapy, smart brain prosthetics, and rapid intervention for psychiatric disorders. Focused ultrasound was selected by the experts for its ability to target tissues deep within the body through the use of sound waves, as opposed to incisions and radiation. According to the announcement by Partners HealthCare, “Focused ultrasound has the ability to revolutionize the treatment of conditions such as brain cancer and Alzheimer’s through its potential for greater precision and quicker patient recovery.”
Partners HealthCare is one of the nation’s leading biomedical research organizations and an integrated health system founded by Brigham and Women’s Hospital and Massachusetts General Hospital. The “Disruptive Dozen” were announced and featured as part of the company’s inaugural World Medical Innovation Forum, April 27-29, 2015.
About The Focused Ultrasound FoundationThe Focused Ultrasound Foundation was created to improve the lives of millions of people worldwide by accelerating the development and adoption of focused ultrasound therapies. The Foundation is dedicated to ensuring that focused ultrasound finds its place as a mainstream therapy for uterine fibroids, cancer, brain tumors, Parkinson's disease, epilepsy, and other life-threatening conditions within years, not decades. Since its establishment in 2006, the Foundation has become the largest non-governmental source of funding for focused ultrasound research. More information about the Charlottesville, Virginia based Foundation can be found at www.fusfoundation.org.